Ji-Won Kim
Patrimonio netto: 38 627 $ in data 30/06/2026
Patrimonio netto: 38 627 $ in data 30/06/2026
Ji-Won Kim currently works at Aju IB Investment Co., Ltd. (Private Equity), as Chief Executive Officer, AJU IB Investment Co., Ltd., as Chief Executive Officer & Director from 1999, and SL VaxiGen, Inc., as Director.
Mr. Kim received his undergraduate degree from Yonsei University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 12.416 ( 0,01% ) | 38 627 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Amministratore Delegato | 01/01/1999 |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Amministratore Delegato | - |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
AJU IB Investment Co., Ltd.
AJU IB Investment Co., Ltd. Investment ManagersFinance Invests in venture and new technology businesses | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale